Betül Yazğan

Betül Yazğan

Auto-generated profile, based on publicly available information

Betül Yazğan

Department of Physiology, Faculty of Medicine Kastamonu University Kastamonu Türkiye

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2016 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
BYBetül Yazğan
Betül Yazğan
YYYENER YAZĞAN
YENER YAZĞAN
İÖİshak Suat Övey
İshak Suat Övey
MNMustafa Nazıroğlu
Mustafa Nazıroğlu

31 January 2024 in Medical Records
Verified
Journal Article
Open access
PDF file
YYYENER YAZĞAN
YENER YAZĞAN
BYBetül Yazğan
Betül Yazğan
Aim: Doxorubicin (DOX), an anthracycline, is widely used in chemotherapy due to its effectiveness in fighting many cancers. Experimental and clinical studies prove that this drug damages non-targeted tissues (including cardiomyocytes) and reduces patients' quality of life during and after DOX treatment. The discovery of potent compounds as a protective tool to slow cardiomyocyte damage during the use of anti-cancer drugs such as DOX is crucial for both more effective cancer treatment and to improve patient's quality of life. Gossypin (GOS) is a flavonoid with several important properties, such as anti-cancer, analgesic, antioxidant, and anti-inflammatory. GOS shows supportive effects against oxidative stress and inflammation by activating antioxidant defense enzymes. Material and Method: For the study, four groups were formed from H9c2 embryonic cardiomyocyte cells as Control, DOX (1 μM, 48 h), GOS25 (25 µg/ml, 48 h), and GOS50 (50 µg/ml, 48 h). In the study, Total antioxidant and oxidant status (TAS and TOS), levels of the inflammatory cytokines IL 1 beta and 6, and TNF α, lipid peroxidation levels as malondialdehyde (MDA), glutathione peroxidase (GSHPx), and glutathione (GSH) levels in the H9c2 embryonic cardiomyocyte cells were determined. Results: The results showed that DOX treatment caused cell toxicity in the embryonic cardiomyocyte cells and increased TOS, IL 1 beta and 6, TNF α, and MDA levels while decreasing TAS, GSH, and GSHPx levels. This situation improved with GOS treatment. Conclusion: As a result, it was determined that GOS treatment showed a protective effect in the DOX-induced cell toxicity model in H9c2 embryonic cardiomyocyte cell lines.

29 September 2023 in Journal of Cellular Neuroscience and Oxidative Stress
Verified
Journal Article
Open access
PDF file
BYBetül Yazğan
Betül Yazğan
YYYENER YAZĞAN
YENER YAZĞAN
Migraine is a complex neurological problem whose primary symptom is headache and is common in the human population. It is well known that neuroinflammation plays a vital role in the pathogenesis of migraine, with adverse effects on the nervous system, including headache disorders such as migraine. The infusion of the nitric oxide donor glyceryl trinitrate (GTN) is often used in experimental models of migraine because it is the best-known model of migraine provocation. N-(p-amyl cinnamoyl) anthranilic acid (ACA) has been shown to inhibit both TRPM2 and phospholipase A2 (PLA2). Recent research has explored potential interventions to mitigate GTN-induced neurotoxicity. One such candidate is ACA, a compound with anti-inflammatory and antioxidant properties. Thirty-six C57BL/6j black mice were divided into the control groups of ACA, GTN, and ACA+GTN. Mice in the ACA were treated intraperitoneally with ACA (25 mg/kg) for three days. Mice in the GTN were treated intraperitoneally with a single dose of GTN (10 mg/kg) for migraine induction. After the experimental stages were completed, the mice in all groups were sacrificed, and brain tissue and erythrocyte samples were taken from the mice. The levels of inflammatory cytokines (TNF α, IL 1β, and IL 6), apoptosis, intracellular ROS, lipid peroxidation, caspase 3-9, and mitochondrial membrane potential increased in the GTN group. However, their levels were decreased in the ACA+GTN group by the injection of ACA. The treatment of ACA regulated the GTN treatment-induced decreases of glutathione levels, glutathione peroxidase activation, and cell viability in the brain and erythrocytes. In conclusion, GTN plays a role in neurotoxicity caused by increased apoptosis and ROS. We observed that ACA modulated the brain and erythrocyte oxidant, antioxidant parameters, and apoptotic processes. The neuro-protective role of ACA treatment may be explained by its modulating activity against increased apoptosis and oxidative stress.

25 December 2024 in Online Türk Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
BYBetül Yazğan
Betül Yazğan
YYYENER YAZĞAN
YENER YAZĞAN
Objective: Cisplatin (CIS) is a powerful chemotherapeutic agent that has long been used alone or in combination in the treatment of various cancers. However, the toxicity of CIS in various tissues limits its use. Gallic acid (GAL) has anti-microbial, anti-inflammatory, and anti-tumor properties. Since GAL has broad biological properties and exhibits antioxidant activity, this study aimed to investigate the effect of GAL on CIS-induced cardiotoxicity in H9c2 cardiomyocyte cell lines. Materials and Methods: H9c2 cardiomyocyte cells as control (CON), CIS, and GAL25, GAL50 in combination along with CIS were used. In the analyses made, glutathione (GSH) and glutathione peroxidase (GSH-Px) enzyme activity, lipid peroxidation levels, inflammation markers IL1β, IL 6, and TNF α, Total Oxidant/ Antioxidant (TOS and TAS) status, reactive oxygen species (ROS) and caspase (Casp 3-9) activity in the cells were determined. Results: CIS treatment caused cardiomyocyte cell toxicity and increased Casp 3-9, ROS, IL 1β, TNF α, IL 6, TOS, and MDA levels while decreasing GSH-Px, GSH, and TAS levels. Increased inflammation and impaired oxidant/antioxidant balance in cardiomyocyte cells after CIS treatment were regulated by GAL treatment. Conclusions: GAL treatment was found to have a protective effect on CIS-induced cardiotoxicity in cardiomyocyte cells.


31 May 2024 in Neuro-Cell Molecular Research
Verified
Journal Article
Closed access
YYYENER YAZĞAN
YENER YAZĞAN
BYBetül Yazğan
Betül Yazğan
Pain is an unpleasant and uncomfortable sensation that informs us that something is wrong and overrides other neuronal signals. Nociceptive pain is an unconscious response of sensory receptors to noxious stimuli. Transient Receptor Potential (TRP) channels are a family of non-selective cation channels located at nociceptive sensory nerve endings that respond to thermal, mechanical, or chemical stimuli with threatening/irritating potential. Depending on the type and intensity of the stimulus, different TRP proteins alter calcium ion permeability and modulate cellular response patterns. TRP Vanilloid Receptor-1 (TRPV1), which has the most crucial role in the activation of pain transmission pathways in this family, is sensitive to vanilloid-like chemicals, temperature (>430C), and low pH. Recent studies indicate that gonadal hormones are actively involved not only in reproductive behavior and sex determination but also in all physiological systems. Current literature shows that gonadal hormones play active roles not only in reproductive behavior and sex determination but also in all physiological systems. Estrogen, the most potent of these hormones, has been the subject of numerous studies due to its vital effects on the nervous system, such as neuronal viability, excitability, and perception of somatosensory stimuli. Although the literature shows that estrogen has essential roles in the modulation of pain, there is insufficient evidence regarding the molecular pathways of its effect. This review aims to investigate the importance of calcium signaling in the molecular pathways of pain and the effects of estrogen on TRPV1 cation channels that alter the calcium ion permeability of nociceptors. FULL TEXT PDF